Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.690
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed

Anixa Biosciences Revenue

In the fiscal year ending October 31, 2023, Anixa Biosciences had annual revenue of $210.00K.

Revenue (ttm)
$210.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
86.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Oct 31, 2023210.00K--
Oct 31, 2022---
Oct 31, 2021512.00K--
Oct 31, 2020---
Oct 31, 2019250.00K-862.50K-77.53%
Oct 31, 2018 Pro Pro Pro
Oct 31, 2017 Pro Pro Pro
Oct 31, 2016 Pro Pro Pro
Oct 31, 2015 Pro Pro Pro
Oct 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CytomX Therapeutics 126.62M
OptimizeRx 88.18M
Exagen 55.75M
LENSAR 48.87M
Coya Therapeutics 9.55M
Monogram Technologies 365.00K
Fractyl Health 97.00K
Revenue Rankings